Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019046952) A SUBCUTANEOUS PHARMACEUTICAL PREPARATION COMPRISING INSULIN(S) AND AN ANTI-INFLAMMATORY AGENT TO REDUCE TISSUE INFLAMMATION RESPONSE IN DIABETIC PATIENTS.
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/046952 International Application No.: PCT/CA2018/051089
Publication Date: 14.03.2019 International Filing Date: 07.09.2018
IPC:
A61K 31/407 (2006.01) ,A61K 38/28 (2006.01) ,A61P 3/10 (2006.01) ,C07D 487/04 (2006.01) ,C07K 14/62 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
40
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
407
condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
22
Hormones
28
Insulins
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3
Drugs for disorders of the metabolism
08
for glucose homeostasis
10
for hyperglycaemia, e.g. antidiabetics
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
04
Ortho-condensed systems
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
14
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435
from animals; from humans
575
Hormones
62
Insulins
Applicants:
SOCIETE DE COMMERCIALISATION DES PRODUITS DE LA RECHERCHE APPLIQUEE SOCPRA SCIENCES SANTE ET HUMAINES S.E.C. [CA/CA]; A/S TransferTech Sherbrooke, Pavillon Irénée-Pinard, 2500, boul. de l'Université, B6-3012 Sherbrooke, Québec J1K 2R1, CA
ADAERATA, LIMITED PARTNERSHIP [CA/CA]; Bureau 12350, 3, Place Ville Marie Montréal, Québec H3B 0E7, CA
Inventors:
ARDILOUZE, Jean-Luc; CA
GOBEIL JUNIOR, Fernand; CA
BAILLARGEON, Jean-Patrice; CA
RABASA-LHORET, Rémi; CA
MÉNARD, Julie; CA
GAGNON-AUGER, Maude; CA
Agent:
NORTON ROSE FULBRIGHT CANADA LLP S.E.N.C.R.L., S.R.L.; Suite 2500 1 Place Ville-Marie Montréal, Québec H3B 1R1, CA
Priority Data:
62/555,93208.09.2017US
Title (EN) A SUBCUTANEOUS PHARMACEUTICAL PREPARATION COMPRISING INSULIN(S) AND AN ANTI-INFLAMMATORY AGENT TO REDUCE TISSUE INFLAMMATION RESPONSE IN DIABETIC PATIENTS.
(FR) PRÉPARATION PHARMACEUTIQUE SOUS-CUTANÉE COMPRENANT UNE OU DES INSULINES ET UN AGENT ANTI-INFLAMMATOIRE POUR RÉDUIRE LA RÉPONSE INFLAMMATOIRE TISSULAIRE CHEZ LES PATIENTS DIABÉTIQUES
Abstract:
(EN) A subcutaneous pharmaceutical composition comprising insulin(s) and an anti-inflammatory agent to treat diabetes and reduce tissue inflammation response in diabetic patients.
(FR) L'invention concerne une composition pharmaceutique sous-cutanée comprenant une ou des insulines et un agent anti-inflammatoire pour traiter le diabète et réduire la réponse inflammatoire tissulaire chez les patients diabétiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)